AFOYX | VMVIX | AFOYX / VMVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 19 years | - |
Gain YTD | 0.185 | 1.900 | 10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 66.9M | 30.9B | 0% |
Annual Yield % from dividends | 1.57 | 2.03 | 77% |
Returns for 1 year | 13.09 | 12.42 | 105% |
Returns for 3 years | 4.29 | 15.30 | 28% |
Returns for 5 years | 28.14 | 38.40 | 73% |
Returns for 10 years | 28.18 | 81.10 | 35% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HERVX | 10.41 | -0.01 | -0.10% |
Hartford Emerging Markets Equity R6 | |||
RYOIX | 69.00 | -0.24 | -0.35% |
Rydex Biotechnology Inv | |||
EPLPX | 22.01 | -0.18 | -0.81% |
NYLI Epoch U.S. Equity Yield Class A | |||
RMFGX | 57.91 | -0.62 | -1.06% |
American Funds American Mutual R6 | |||
GCTAX | 46.95 | -1.02 | -2.13% |
Goldman Sachs US Tax-Managed Eq A |